Skip to content
CDMO SERVICES FOR PROTEINS & ANTIBODIES

Biosimilars and Biobetters

You want to create a high-performance biosimilar or a biobetter with improved product properties at a reasonable cost? 

Our expertise in generating mammalian cell-derived biosimilars has been honed for over a decade and helps us ensure reliability and rapid progress. Transitioning seamlessly from market-ready biosimilars to our innovative biobetters, we pave the way for cost-effective solutions that elevate patient care. 

IN A NUTSHELL

Biosimilars and Biobetters for Affordable Treatments

Relying on our proprietary technologies, we provide you with a smart cell line and process development as well as the secure manufacture of clinical batches in a timely manner. The entire process is monitored and controlled by head-to-head comparison to the reference medicinal product (RMP) and complemented by a biosimilarity assessment to ensure similarity. 

ProBioGen Biosimilars and Biobetters
HOW WE WORK

Our Expertise - Your Success

One-Stop-Shop
Fully Centered on Quality and Compliance
Proprietary Vectors, Media Platform and Best-in-Class Technologies
Integrated Analytics
Process Development for Biosimilars
Product Characterization & Biosimilarity Assessment

Types of Molecules We’ve Worked With

Biosimilars and Biobetters Molecule List

Our Promise To You

Asset 20
 
Comparability Secured
  • Comprehensive originator assessment for a reliable quality target product profile (QTPP) 
  • Early biosimilar candidate testing to adjust and align with the critical quality attributes (CQA)  
  • Superior technologies to adjust and boost performance 
Asset 68
 
Maximum Reliability
  • Highly experienced project teams headed by our project management office (PMO) 
  • Integrated development, GMP manufacturing, and analytics 
  • Similarity and compliance through quality by design (QbD)
Time is Money
 
Reasonable Costs and Timelines
  • Efficient process development, manufacturing, and reports 
  • Cost efficient development and manufacturing achieved by controlling the cost of goods (CoGs) and scaling to demand  
  • Fast track approach with accelerated timelines in CLD, USP, and DSP

Elevate Your Candidate With The Right CDMO

Discover Related Services

Explore Protein Technologies

Explore Related Content

Blog Header template-1
Sugar-Sweet Success: Enhancing Antibody Therapeutics Through Precision Glycoengineering

Blog Post

Read More
Process_Intensification_in_Upstream_Processing_Blog_small-1
Investing in Efficiency: Benefits of Process Intensification in Upstream Processing

Blog Post

Read More
ProBioGen_Laboratory_Media_100px
ProBioGen Enters Agreement with Polpharma Biologics to Provide High-Performance Cell Line Development Services

Press Release

Read More
L1430743_ProBioGen_PCLD_Supplementierung_Zellkulturmedium_100px_gedreht
GlymaxX®-Enhanced Antibody Now Commercially Available for Innovative Cancer Therapy

Press Release

Read More
Newsletter
Join for ProBioGen News - make sure to be always up-to-date and fully informed with our latest company announcements.